Medulloblastoma (MB) is a malignant brain tumor that arises in the cerebellum of children. Activation of the Sonic hedgehog/Patched (Shh/Ptc) signaling pathway in neural progenitor cells of the cerebellum induces MBs in mice. The incomplete penetrance of tumor formation in mice, coupled with the low frequency of mutations in Shh/ Ptc pathway genes in human tumors, suggests that other signaling molecules cooperate with Shh to enhance MB formation. We modeled the ability of insulin-like growth factor (IGF) signaling to induce MB using the RCAS/tv-a system, which allows postnatal gene transfer and expression in a cell-type-specific manner. We used RCAS retroviral vectors to target expression of Shh, IGF2, and activated Akt to nestin-expressing neural progenitors in the cerebella of newborn mice. The incidence of Shhinduced tumor formation (15%) was enhanced by coexpression with IGF2 (39%) and Akt (48%). Neither IGF2 nor Akt caused tumors when expressed independently. The induced tumors showed upregulated expression of insulin receptor substrate 1 and phosphorylated forms of IGF1 receptor and Akt, mimicking activated IGF signaling found in human MBs. These results indicate that combined activation of the Shh/Ptc and IGF signaling pathways is an important mechanism in MB pathogenesis.
Medulloblastoma (MB) is a malignant brain tumor that arises in the cerebellum of children. The most likely cells-of-origin are granule neuron precursors (GNPs), which occupy the external granule layer (EGL) of the developing cerebellum. Activation of signaling pathways that stimulate proliferation and/or block differentiation of neural progenitor cells in the cerebellum is thought to initiate MB formation (reviewed by Wechsler-Reya and Scott, 2001) .
Considerable attention has been focused on the role of the Sonic hedgehog/Patched (Shh/Ptc) signaling pathway in the genesis of MB. Inherited mutations in the human PTC gene, which encodes the Shh receptor, segregate in families with nevoid basal cell carcinoma syndrome (Gorlin's Syndrome), wherein affected individuals develop craniofacial abnormalities and predisposition to various types of tumors, including MB (Hahn et al., 1996; Johnson et al., 1996) . Somatic PTC gene mutations occur in 3-14% of sporadic MBs (Pietsch et al., 1997; Raffel et al., 1997; Wolter et al., 1997) . Knockout mice that are heterozygous defective for Ptc are predisposed to MB formation (Goodrich et al., 1997; Hahn et al., 1998) . We reported previously that targeting expression of Shh to neural progenitors in the cerebellum of newborn mice induces hyperplasia of the EGL and MB (Rao et al., 2003) . Other investigators have induced MBs in mice by retroviral transfer of Shh to the cerebellum in utero (Weiner et al., 2002) .
While these observations implicate Shh/Ptc signaling as a causative factor for MB, there is mounting evidence that this pathway is not the sole determinant of MB formation. The frequency of mutations in Shh/Ptc pathway genes in human MBs is very low (Zurawel et al., 2000) . MBs arise in only 14% of Ptc þ /À mice within the first year of life (Wetmore et al., 2000) and tumor incidence is highly strain-dependent (CalzadaWack et al., 2002) .
Molecular oncology studies in humans and mice implicate insulin-like growth factors (IGFs) as additional, causative factors for MB. Transcriptional profiling of human MBs using DNA microarrays has shown increased expression of IGF2, mainly in the desmoplastic subtype (Pomeroy et al., 2002) . Homozygous deletion of the Igf2 gene completely eliminates MB formation in Ptc þ /À mice, suggesting a requirement for IGF2 or downstream signaling molecules in MB oncogenesis (Hahn et al., 2000) .
Many lines of evidence indicate that the physiological effects of IGF2 are mediated by the IGF1 receptor (IGF1R), a receptor tyrosine kinase (reviewed by Khandwala et al., 2000) . Phosphorylation of insulin receptor substrate 1 (IRS-1) by activated IGF1R creates a docking site for the regulatory subunit of phosphoinositide 3 kinase (PI3K). Consequent activation of the catalytic subunit of PI3K generates phosphatidylinositol (3,4,5) trisphosphate, which recruits serine/threonine kinase, Akt (protein kinase B), to the plasma membrane, where phosphorylation of Akt at residues S473 and T308 activates the Akt kinase (reviewed by Cantley, 2002) .
MB cell lines derived from transgenic mice expressing JC virus T-antigen show upregulated expression of IRS-1, and exogenous IGF1 stimulates these cell lines to proliferate (Wang et al., 2001) . Immunohistochemical studies of primary human MBs have shown expression of IRS-1 and phosphorylated (activated) IGF1R (Del Valle et al., 2002) . It is not known whether stimulation of IGF signaling in the developing cerebellum is sufficient to induce MB formation in vivo or whether cooperation with Shh/Ptc signaling is required.
To evaluate the role of IGF signaling in MB formation in vivo, we used the RCAS/tv-a system, which allows postnatal gene transfer in a cell-type-specific manner (Federspiel et al., 1994; Holland and Varmus, 1998) . We utilized replication-competent ALV spliceacceptor (RCAS) vectors, derived from the avian retrovirus ALV (subgroup A), and a transgenic mouse line (Ntv-a) that produces TVA (the receptor for ALV-A) under control of the Nestin gene promoter. Nestin is an intermediate filament protein expressed by neuronal and glial progenitors (Lendahl et al., 1990) . When mammalian cells are infected with RCAS vectors, viral replication does not occur and the transferred gene is expressed as a spliced message under control of the constitutive retroviral promoter, LTR.
We transferred IGF2 and Shh, alone and in combination, to nestin-expressing, neural progenitor cells in the cerebella of newborn, Ntv-a mice by injecting ALV-A producer cells (DF1 chicken fibroblasts infected with and expressing RCAS vectors). We injected virus producer cells rather than cell-free virus stocks in order to achieve persistently high virus titers at the injection sites. After injection, producer cells survive for less than 3 days and transfer genes to a few hundred cells surrounding the needle track (Holland and Varmus, 1998) . To verify the production of infectious virus, we infected tv-a þ brain cultures with producer cell supernatant and demonstrated expression of the appropriate gene products on Western blots (Figure 1a) . We analysed the brains of injected mice after 12 weeks, or sooner if the mice developed macrocephaly or became debilitated. MBs developed in 6/41 mice (15%) injected with RCAS-Shh, an incidence comparable to that we reported previously (Rao et al., 2003) . Mice injected with RCAS-Shh þ RCAS-IGF2 developed tumors in 19/ 49 cases (39%), a higher tumor incidence than with RCAS-Shh (P ¼ 0.01) ( Table 1) . No tumors formed in mice injected with RCAS-IGF2 alone.
We cannot exclude the possibility that transfer of IGF2 may have had non-transforming effects, like the enhanced cell migration induced in mouse forebrain astrocytes by basic fibroblast growth factor (Holland and Varmus, 1998) . We did visualize scattered, HAtagged neurons in the cerebellar cortex, brain stem, and forebrain of mice injected with RCAS-IGF2 but not in uninjected controls, indicating that IGF2-expressing neural progenitor cells can migrate widely throughout the brain and differentiate (not shown).
The tumors induced by Shh þ IGF2 arose in the dorsolateral cerebellum and sometimes infiltrated the adjacent brain stem (Figure 1b) . Microscopically, these tumors closely resembled classical MBs in humans and they appeared identical to the tumors we induced in mice by injecting RCAS-Shh alone. They were composed of densely packed sheets of cells with hyperchromatic nuclei and scant cytoplasm, and showed focal expression of synaptophysin, a reliable histopathological marker for MB (Coffin et al., 1990) (Figure 1c To assess the differentiation status of the MBs induced by Shh þ IGF2, we carried out an immunocytochemical analysis of five tumor-bearing mouse brains using antibodies specific for glial fibrillary acidic protein (GFAP), neurofilament protein, NeuN, and bIII tubulin. The tumor cells expressed bIII tubulin in the cytoplasm and NeuN in the nucleus. These proteins are expressed by normal neural progenitors at the onset of their differentiation into neurons (Mullen et al., 1992; Easter et al., 1993) . We did not detect neurofilament protein, a marker for terminally differentiated neurons. GFAP immunoreactivity was visible only in processes of entrapped astrocytes interdigitated among unstained tumor cells. This antigenic profile is identical to that we reported previously in Shh-induced MBs and supports an origin of these tumors from neuronal precursors (Rao et al., 2003) .
If sustained IGF signaling is required to maintain tumor growth in vivo, then MBs induced by Shh, independently or in combination with IGF2, should show activated IGF signaling components. To examine this, we carried out immunoperoxidase staining of tumor-bearing brain sections with antibodies against IGF1R, IRS-1, and phosphorylated (activated) forms of IGF1R and Akt. Using an antibody that specifically recognizes phosphotyrosine 1316 (pY1316) on the b subunit of IGF1R and does not crossreact with the corresponding moiety of the activated insulin receptor (Rubini et al., 1999) , we found intense immunoreactive staining in the cytoplasm of tumor cells in MBs induced by Shh and Shh þ IGF2 (Figure 2a ). In the adjacent cerebellar cortex, there was weak staining in the axonrich molecular layer, but no staining in cell bodies in the Purkinje or internal granule layers (Figure 2b ). When we probed facing tissue sections with an antibody recognizing total IGF1R, we found uniform staining throughout the tumor cells as well as Purkinje and internal granule neurons (not shown). IRS-1 (the major phosphorylation substrate for IGF1R) was expressed both in MBs induced by Shh and in those induced by Shh þ IGF2 (Figure 2c ), but was undetectable in the cerebellum (Figure 2d ).
For detecting activated Akt, we used an antibody that specifically recognizes phosphoserine 473 (pS473). The crystal structure of Akt shows that S473 phosphorylation is required for catalytic activation by making ATP binding possible (Yang et al., 2002) . We found intense cytoplasmic staining for pS473Akt in the tumor cells in MBs induced by Shh and Shh þ IGF2 Figure 1 Histopathology of MBs induced by RCAS-mediated transfer and expression of IGF2 þ Shh. DF-1 chicken fibroblasts, infected with and producing RCAS vectors expressing Shh and IGF2, were injected into the cerebellum of newborn, Ntv-a mice. Each mouse was injected with 2 ml of producer cells (10 5 in phosphate-buffered saline) from an entry point approximately 2 mm lateral to the midline at the lambdoid suture of the skull. Immunoperoxidase staining of producer cell cultures with antibodies against epitope tags on the encoded proteins showed positive staining in 100% of cells. To show that our RCAS-IGF2 vector could produce infectious virus capable of transferring and expressing IGF2 in tv-a þ cells, we performed Western blot analysis of primary brain cultures from Ntv-a mice before and after infection with producer cell supernatant (a). A 27 kDa band corresponding to HA-tagged IGF2 was detected with anti-HA antibody in infected cells ( þ ) but not uninfected cells (À). Previous publications have demonstrated similar results with RCAS-Akt and RCAS-Shh (Holland et al., 2000; Rao et al., 2003) . Brains were fixed in phosphate-buffered formalin (10%) and sectioned (4 mm) for immunohistochemical analysis. To analyse protein expression in tissue sections, we used immunoperoxidase staining methods described previously (Fults and Pedone, 2000) . The induced tumors arose from the dorsolateral cerebellum (b) and displayed cytoarchitecture (c) mimicking classical human MB, including mitotic figures (arrow) and expression of synaptophysin (d). Immunoperoxidase staining with monoclonal antibodies against HA (e) and Myc (f) epitopes showed expression in tumor cells of virally transduced IGF2 and Shh, respectively. We used monoclonal antibodies, 9E10 (1 : 50) against human c-Myc, and F7 (1 : 50) against HA (both from Santa Cruz Biotechnology; Santa Cruz, CA, USA). Scale bar ¼ 2.5 mm (b), 20 mm (c-f) Sonic hedgehog and IGF2 induce medulloblastoma G Rao et al (Figure 2e ). In the cerebellum, pS473Akt expression was found only in Golgi neurons.
To demonstrate a functional role for Akt activation in MB, we used an RCAS vector to transfer an activated, transforming allele of Akt (Akt-Myr-D11-60) to nestinexpressing cerebellar progenitors in Ntv-a mice. This allele contains an amino-terminal myristylation signal, which enhances Akt's affinity for the plasma membrane (Aoki et al., 1998) . Transfer of Akt-Myr-D11-60 þ activated Ras to neural progenitor cells in the forebrain of mice induces glioblastoma, a malignant astroglial tumor that typically arises in adults (Holland et al., 2000) . We found that Akt-Myr-D11-60 had an enhancing effect on Shh-induced MB formation comparable to that of IGF2 (Table 1) To determine whether the activated IGF/PI3K signaling in our mouse model accurately reflected the molecular pathogenesis of human MBs, we probed a Western blot of surgical specimens from six patients with cerebellar MBs with antibodies recognizing total Akt and pS473 Akt. We estimated the background level of phospho-Akt in normal brain using peritumoral brain tissue removed during wide surgical resection of a lowgrade (non-malignant) astrocytoma. For positive controls, we tested two glioblastoma specimens, a tumor type that frequently shows Akt activation (Holland et al., 2000) . We also tested two primitive neuroectodermal tumors (PNETs) from the cerebral hemisphere, a type of pediatric brain tumor resembling MB histologically. Immunoreactivity for pS473Akt was increased compared to normal brain in 4/6 (67%) of MBs ( Figure 3a, lanes 2, 6, 8, 9 ). The two PNETs did not show significant pS473Akt immunoreactivity (Figure 3a , lanes 3 and 4).
We surveyed an additional 20 MBs by immunoperoxidase staining of formalin-fixed, paraffin-embedded tissue sections using the anti-pS473Akt antibody. Unlike the tumors analysed by Western blotting, the 20 immunohistochemistry specimens were obtained from pathology archives and therefore were not controlled for expeditious tissue processing needed to insure preservation of labile phosphoproteins. Nevertheless, we detected immunoreactive staining for pS473Akt in 16/20 (80%) specimens (Figure 3b) . Interestingly, pS473Akt localized to the nucleus in most of the human tumor specimens (Figure 3c1 ). Nuclear localization of phospho-Akt has been shown in human microvascular endothelial cells in which intracellular trafficking of Akt is controlled by RhoB, a small GTPase involved in cell motility and migration (Adini et al., 2003) .
Immunocytochemical analysis of 17 human MBs, published previously by some of us (LDV, KR), showed that phosphorylated IGF1R and IRS-1 were expressed in 59 and 71% of cases, respectively (Del Valle et al., 2002) . In the present study, we tested three additional human MBs and found abundant immunoreactivity for IRS-1 and pY1316 IGF1R in all cases (Figure 3c2 and c4 show one example). In the adjacent cerebellar cortex, there was faint immunoreactive staining for pY1316 IGF1R in the cell bodies of Purkinje neurons ( Figure  3c3 ), but no detectable expression of IRS-1 (Figure 3c5 ). Taken together, these results indicate that PI3K signaling, as measured by expression of pS473Akt, phosphorylated IGF1R, and IRS-1, is frequently activated in primary human MBs.
Several different genetic manipulations in mice have shown that activating the Shh/Ptc signaling pathway in the developing cerebellum is sufficient to induce MBs (Goodrich et al., 1997; Hahn et al., 1998; Weiner et al., 2002; Rao et al., 2003) . The incomplete penetrance of tumor formation in these mouse models suggests that other signaling molecules cooperate with Shh to enhance MB oncogenesis. Using the RCAS/tv-a system, we previously identified the c-Myc oncoprotein as one of these enhancing molecules (Rao et al., 2003) . The current study shows that IGF2 and Akt also potentiate MB formation when coexpressed with Shh.
Two experimental observations in Ptc-deficient mice suggest that IGF2 may be a downstream, transcriptional target for Shh. First, IGF2 is required for spontaneous MB formation. Second, IGF2 expression is increased Figure 3 Expression of IGF signaling proteins in primary human MBs. For Western blotting analysis of human brain tumors (a), we used methods described previously (Holland et al., 2000) . Primary antibodies for total Akt (lower) or pS473Akt (upper) were used at 1 : 1000 dilution (Cell Signaling Technology, Beverly, MA, USA). The two bands detected with the antibody against total Akt result from retarded electrophoretic mobility of phospho-Akt compared to unphosphorylated Akt. To quantify pS473 expression in paraffin-embedded MB specimens (b), we counted the percentage of tumor cells showing pS473 immunoreactivity in 4-5 40 Â microscope fields (41000 cells counted per specimen). Immunocytochemical analysis of human MBs (panel c) showed expression of pS473 in the nucleus (arrowhead) and cytoplasm (arrow) of tumor cells (c1) and cytoplasmic expression of pY1316 IGF1R (c2) and IRS-1 (c4). In the adjacent cerebellar cortex, expression of pY1316 IGF1R (c3) and IRS-1 (c5) was negligible. For immunocytochemistry, we used polyclonal antibodies for pY1316 IGF1R (1 : 500) and IRS-1 (1 : 1000), as described in Figure 2 . Scale bar ¼ 32 mm (c1), 20 mm (c2-c5) Sonic hedgehog and IGF2 induce medulloblastoma G Rao et al both in tumors and in normal tissues from these mice (Hahn et al., 2000) . The fact that neither IGF2 nor Akt could substitute for Shh in our mouse model of MB indicates that the tumorigenic effects of Shh are not mediated solely by activating IGF/PI3K signaling. Transcriptional profiling studies have shown that Shh stimulation of GNPs in culture upregulates broad classes of genes governing diverse cellular functions, but not IGF signaling genes, specifically (Zhao et al., 2002; Oliver et al., 2003) .
A recent publication described a mechanism through which Shh/Ptc and PI3K signaling pathways might cooperate to promote MB formation by converging upon the oncoprotein, N-Myc (Kenney et al., 2004) . That study showed that PI3K signaling inhibits glycogen synthase kinase 3-dependent phosphorylation and consequent degradation of N-Myc in cultured GNPs. Coupled with the fact that N-Myc is a direct transcriptional target of Shh (Kenney et al., 2003; Oliver et al., 2003) , the discovery that PI3K signaling stabilizes NMyc offers an explanation for the enhancing effect of IGF2 and Akt on Shh-induced MB formation in our Ntv-a mice. In support of this, we found N-Myc immunoreactive staining in MBs induced by Shh, Shh þ IGF2, and Shh þ Akt (Figure 2f shows results with Shh). The semiquantitative nature of immunocytochemistry did not make it possible to ascertain whether the amount of N-Myc protein in Shh-induced tumors was enhanced by addition of IGF2 or Akt-Myr-D11-60.
The signaling molecules that cooperate to induce MB, when overexpressed in the mouse cerebellum, are relevant to the pathogenesis of human tumors. Primary human MBs express Ptc and Gli transcription factors, indicating activation of the Shh/Ptc pathway (Dahmane et al., 2001) . Human MBs express activated IGF1R and its phosphorylation substrate, IRS-1, and activated Akt, indicating activation of IGF-mediated PI3K signaling. These results indicate that combined activation of the Shh/Ptc and IGF signaling pathways is an important pathogenic mechanism in MB.
